Remission of the renal involvement in a patient with primary Sjögren's syndrome (SS) after pulse high-dose corticosteroid infusion therapy.
We report the case of a young female patient with primary Sjögren's syndrome (SS). In addition to sicca symptoms she also suffered from progressive renal insufficiency and renal tubular acidosis (RTA). She was treated with three sets of pulse high-dose corticosteroid infusion and subsequent low-dose corticosteroid oral administration. When the efficacy was evaluated about 6 months after the start of the therapy, dramatic improvements were seen with no adverse effects, not only in laboratory tests but also histopathologically, as indicated by the repeat kidney biopsy. This suggests that renal involvements of SS might be reversible in some cases, and that there might be a clinical benefit of pulse high-dose corticosteroid infusion therapy in SS with progressive renal involvement.
Saeki
Y
Y
Department of Molecular Medicine, Osaka University Medical School, Suita City, Japan.
Ohshima
S
S
Ishida
T
T
Shima
Y
Y
Umeshita-Sasai
M
M
Nishioka
K
K
Yamaguchi
N
N
Suemura
M
M
D000141:Acidosis, Renal Tubular / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology*; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D008775:Methylprednisolone / Q000008:administration & dosage / Q000627:therapeutic use*; D009395:Nephritis, Interstitial / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology*; D020551:Pulse Therapy, Drug; D012859:Sjogren's Syndrome / Q000150:complications* / Q000188:drug therapy*
D000893:Anti-Inflammatory Agents; D008775:Methylprednisolone